Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years

Allogeneic hematopoietic stem cell transplantation (HSCT) is an integral therapy for patients with hematological malignancies, myelodysplasia, and bone marrow failure. Its use has been increasing over the past decade, as understanding of the treatment and its related toxicities has led to changes in...

詳細記述

書誌詳細

主要な著者:	Curtis Lachowiez, Rachel J. Cook, Brandon Hayes-Lattin, Richard T. Maziarz, Uma Borate, Elie Traer, Jessica Leonard, Laura Newell, Kim-Hien Dao, Gabrielle Meyers
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wolters Kluwer Medknow Publications 2019-01-01
シリーズ:	Hematology/Oncology and Stem Cell Therapy
主題:	acute myeloid leukemia allogeneic stem cell transplant bone marrow transplant flt-3 hypomethylating agent induction chemotherapy leukemia myelodysplastic syndrome targeted therapy
オンライン･アクセス:	https://journals.lww.com/10.1016/j.hemonc.2019.01.002
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!